# ERLOTINIB HYDROCHLORIDE
> **ANDA216342** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-06-22
## Drug
- **FDA Application Number:** ANDA216342
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERLOTINIB HYDROCHLORIDE
- **Generic name:** ERLOTINIB
- **Active ingredients:** ERLOTINIB HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** EUGIA PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2022-06-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216342)
---
*MORVS · CC0 1.0*